These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2263084)

  • 1. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.
    Richards WO; Geer R; O'Dorisio TM; Robarts T; Parish KL; Rice D; Woltering G; Abumrad NN
    J Surg Res; 1990 Dec; 49(6):483-7. PubMed ID: 2263084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
    Geer RJ; Richards WO; O'Dorisio TM; Woltering EO; Williams S; Rice D; Abumrad NN
    Ann Surg; 1990 Dec; 212(6):678-87. PubMed ID: 2256759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nonendocrine gastrointestinal disorders with octreotide acetate.
    Woltering EA; O'Dorisio TM; Williams ST; Lebrado L; Fletcher WS
    Metabolism; 1990 Sep; 39(9 Suppl 2):176-9. PubMed ID: 1976212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis.
    Edmunds MC; Chen JD; Soykan I; Lin Z; McCallum RW
    Aliment Pharmacol Ther; 1998 Feb; 12(2):167-74. PubMed ID: 9692691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in dumping and short bowel syndromes.
    Farthing MJ
    Digestion; 1993; 54 Suppl 1():47-52. PubMed ID: 8359568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long acting somatostatin analogue in dumping syndrome.
    Tulassay Z; Tulassay T; Gupta R; Cierny G
    Br J Surg; 1989 Dec; 76(12):1294-5. PubMed ID: 2691013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide improves early dumping syndrome potentially through incretins: a case report.
    Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
    Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery.
    Gray JL; Debas HT; Mulvihill SJ
    Arch Surg; 1991 Oct; 126(10):1231-5; discussion 1235-6. PubMed ID: 1929823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of octreotide on manometric variables in patients with neuropathic abnormalities of the small bowel.
    Bassotti G; Germani U; Calcara C; Spinozzi F; Roselli P; Morelli A
    Dig Dis Sci; 1997 Aug; 42(8):1634-9. PubMed ID: 9286228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The place of octreotide in the medical management of the dumping syndrome.
    Scarpignato C
    Digestion; 1996; 57 Suppl 1():114-8. PubMed ID: 8813487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.
    Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH
    Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
    Soudah HC; Hasler WL; Owyang C
    N Engl J Med; 1991 Nov; 325(21):1461-7. PubMed ID: 1944424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders.
    Haruma K; Wiste JA; Camilleri M
    Gut; 1994 Aug; 35(8):1064-9. PubMed ID: 7926907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
    Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
    J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1359-65. PubMed ID: 8667198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute postoperative ileus with octreotide.
    Cullen JJ; Eagon JC; Dozois EJ; Kelly KA
    Am J Surg; 1993 Jan; 165(1):113-9; discussion 119-20. PubMed ID: 8418686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The action of octreotide in dumping syndrome].
    Hölscher AH
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():45-9. PubMed ID: 2281705
    [No Abstract]   [Full Text] [Related]  

  • 19. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis.
    Lawaetz O; Blackburn AM; Bloom SR; Aritas Y; Ralphs DN
    Scand J Gastroenterol; 1983 Jan; 18(1):73-80. PubMed ID: 6372067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postgastrectomy dumping treated with octreotide (Sandostatin)].
    Møller TD; Carlsen CU
    Ugeskr Laeger; 1993 Jun; 155(23):1805-6. PubMed ID: 8317033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.